tiprankstipranks
Trending News
More News >

EVE Health Group Completes Share Consolidation

Story Highlights
EVE Health Group Completes Share Consolidation

Don’t Miss TipRanks’ Half-Year Sale

EVE Health Group Limited ( (AU:EVE) ) just unveiled an update.

EVE Health Group has completed a share consolidation on a forty-to-one basis, as approved by shareholders. This move results in a new capital structure with 131,862,715 ordinary shares. The consolidation aims to streamline the company’s capital structure, potentially enhancing its market position and operational efficiency. Trading on a normal T+2 settlement basis will resume on 12 June 2025.

More about EVE Health Group Limited

EVE Health Group (ASX: EVE) is an Australian-based health company focused on developing and commercializing evidence-based wellness and pharmaceutical products. Through its subsidiaries, Meluka Australia and the soon-to-be-acquired Nextract, EVE provides science-led innovations for consumer and practitioner health across retail, pharmacy, and clinical channels.

Average Trading Volume: 1,278,384

Technical Sentiment Signal: Sell

Current Market Cap: A$4.75M

Learn more about EVE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1